tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Ownership - Who Owns Phathom Pharmaceuticals?

Compare
523 Followers

Phathom Pharmaceuticals (PHAT) Ownership Overview

11.06%10.22%52.55%7.94%18.23%
11.06% Insiders
52.55% Other Institutional Investors
7.94% ETFs
18.23% Public Companies and
Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 70.71% of the company’s stock is owned by Institutional Investors, 11.06% is owned by Insiders, and 18.23% is owned by Public Companies and Individual Investors.
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 62.77% of the company’s stock is owned by Institutional Investors, 11.06% is owned by Insiders, and 7.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 09, 2025
xxxxxxxxxxxxx
$5573
Jul 18, 2025
xxxxxxxxxxxxx
$14145
May 23, 2025
xxxxxxxxxxxxx
$14591
May 15, 2025
xxxxxxxxxxxxx
$24455

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$300723
Jun 30, 2025
xxxxxxxxxxxxx
$1796120
Jun 30, 2025
xxxxxxxxxxxxx
$5754000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,933,327Insider8.36%68,114,594
2,413,668Institution3.40%27,708,909
2,301,862Institution3.24%26,425,376
1,910,647Institution2.69%21,934,228
1,252,471Institution1.77%14,378,367
1,101,868Insider1.55%12,649,445
746,710Institution1.05%8,572,231
600,000Institution0.85%6,888,000
578,694Institution0.82%6,643,407
469,987Institution0.66%5,395,451

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,301,862Institution3.24%26,425,376
1,252,471Institution1.77%14,378,367
746,710Institution1.05%8,572,231
469,987Institution0.66%5,395,451
464,839Institution0.66%5,336,352
459,193Institution0.65%5,271,536
253,000Institution0.36%2,904,440
232,274Institution0.33%2,666,506
221,065Institution0.31%2,537,826
119,905Institution0.17%1,376,509

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,554,088Institution2.19%13,271,912
1,054,497Institution1.49%12,105,626
496,316Institution0.70%4,238,539
321,935Institution0.45%3,695,814
286,201Institution0.40%3,285,587
285,172Institution0.40%3,273,775
269,371Institution0.38%3,092,379
227,046Institution0.32%2,606,488
217,687Institution0.31%2,577,414
201,523Institution0.28%1,721,006

FAQ

Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 52.55% of the company's stock is held by institutional investors, 11.06% is held by insiders, and 18.23% is held by retail investors.
    What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 52.55% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
      What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 18.23% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
        Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
        James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis